Relay Therapeutics, Inc. (RLAY) Return On Equity % [USD] 2019 - 2023

Historical data

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Relay Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Relay Therapeutics, Inc. Return On Equity for the quarter ending March 31, 2024 was -42.7 %, a 19.4% decline year-over-year.
  • Relay Therapeutics, Inc. annual Return On Equity for 2023 was -42.4 %, a 30.4% decline from 2022.
  • Relay Therapeutics, Inc. annual Return On Equity for 2022 was -32.5 %, a 37% increase from 2021.
  • Relay Therapeutics, Inc. annual Return On Equity for 2021 was -51.6 %, a 158% decline from 2020.
Return On Equity, Annual (% [USD])
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -42.4 -9.89 -30.4% Jan 1, 2023 Dec 31, 2023
2022 -32.5 +19.1 +37% Jan 1, 2022 Dec 31, 2022
2021 -51.6 -31.6 -158% Jan 1, 2021 Dec 31, 2021
2020 -20 -70 -140% Jan 1, 2020 Dec 31, 2020
2019 50 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.